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and those associated with livestock-associated 218 MRSA (Gómez-Sanz et al., 2013) . pressure (Loeffler et al., 2007; Perreten et al., 2010; Detwiler et al., 2014; McCarthy et al., 2015) .
227
First reported from dogs in North America in the late 1990s (then MRSI), MRSP accounted 228 for over 30% of staphylococcal isolates from American dogs within less than ten years (Gortel et 229 al.,1999; Morris et al., 2006; Jones et al., 2007) and is now identified worldwide. An even higher 230 prevalence was recently reported from China and Japan with nearly 50% and 70%, respectively 231 (Feng et al., 2012; Kasai et al., 2016) . In the UK, where MRSP was first recognised in 2009, the 232 burden seems relatively low with rates below 5% of clinical S. pseudintermedius laboratory 233 submissions reported in 2015 (Maluping et al., 2014; Beever et al., 2015) . In contrast, studies from 234 continental Europe, where MRSP had been identified three years earlier, prevalence was soon
Clinical implications and early identification 242
Clinically, MRS infections in animals are no different from infections involving less 243 resistant staphylococci ( Fig. 1) (Morris et al., 2017) . In fact, early case-control studies showed that 244 clinical outcome was no worse for MRSA and MRSP infections in pets compared to those 245 involving their susceptible counterparts, provided that a safe antibacterial treatment option was 246 available (Weese et al., 2012; Lehner et al., 2014) . Finding treatment options may be troublesome 247 and treatment has been shown to take longer than with susceptible staphylococci (Bryan et al., 248 2012). However, the bigger concern with MRS pyoderma is its potential for spreading these 249 zoonotic, multidrug-resistant pathogens to other animals and people, and into the environment. For 250 MRSP, the risk of zoonotic transmission is generally considered low as low carriage rates of S.
251
(pseud)intermedius have been found in people regularly exposed to dogs (Havey et al. 1994; 252 Goodacre et al., 1997; Han et al., 2016) . As for all staphylococci though, the risk is increased for (Stegman et al., 2010; Somayaji et al., 2016; Lozano et al., 2017) .
256
Transmission of staphylococci is supported by their ability to survive on dry surfaces and at 257 healthy skin and mucosal carriage sites for many months, equipping them for nosocomial spread 258 (Wagenvoort et al., 2000; Windahl et al. 2016 (Medleau et al., 1986; Kruse et al., 1996; 306 Lloyd et al., 1996; Pellerin et al., 1998; Normand et al., 2000) . It was already recognised that 307 isolates from animals that had repeatedly received antimicrobials were likely to show more canine clinical isolates and, in the UK, there is now evidence that resistance to most antimicrobial 312 classes is gradually increasing (Beever et al., 2015) . Based on recent data for small animal 313 pathogens, this trend of increasing AMR is likely to continue worldwide (Ludwig et al., 2016) .
Topical therapy 316
Topical antibacterial therapy has always been advised for surface infections and, in 317 combination with systemic therapy, for superficial and deep pyoderma (Ihrke, 1987; Curtis, 1998 Curtis, & 318 1999 . However, newer studies have provided good evidence that topical therapy can be effective as have not yet led to the development of veterinary products (Table 2) .
460
It is likely that at least some of these new approaches will prove successful, however we 461 should not expect the development of agents which will allow us to ignore good drug stewardship 462 and the adoption of rigorous hygiene.
464

Conclusions
465
Canine pyoderma will need to be managed appropriately to reduce morbidity and to limit 466 the spread of potentially MDR pathogens amongst pets and humans. However, the availability of 467 effective and safe systemic antimicrobials will become -or already is in some countries -468 substantially limited, either by continued selection of antimicrobial resistance amongst pathogens or by legislative restrictions on prescribing by veterinary surgeons. We will likely need to adapt our 
